Signos
Offers continuous glucose monitoring paired with AI for personalized weight loss.
What they do
Signos combines continuous glucose monitors with an AI-driven mobile app to provide real-time metabolic data. The platform helps individuals track glucose spikes and receive personalized recommendations for diet and exercise to achieve healthy weight loss.
The record
- Vertical
- Metabolic Health
- Sub-segment
- Metabolic tracking
- Product type
- Platform software
- Stage
- Series B
- Headquarters
- San Mateo, USA
- Region
- North America
- Founded
- 2018
- Total funding
- $37M raised
Notable investors: Cheyenne Ventures, Dexcom Ventures, GV.